
Free Daily Podcast Summary
by Kunal Sampat | Educator
Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career. You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals.
The most recent episodes — sign up to get AI-powered summaries of each one.
Investigational drug clinical trials depend on far more than protocol design, patient recruitment, and data collection. A critical part of trial execution is the pharmacy team responsible for supporting the study. These specialized pharmacy teams are often known as Investigational Drug Services, or IDS. They help ensure that the right investigational drug, at the right dose, is administered to the right participant, at the right time, and in compliance with the clinical trial protocol. In this episode of the Clinical Trial Podcast, Dr. Kevin Zinchuk joins the conversation to explain the role of Investigational Drug Services in clinical trials. Kevin is the Pharmacy Manager for Investigational Drug Services at Brigham and Women's Hospital, where he works closely with researchers across the public and private sectors to conceptualize, develop, and operationalize interventional clinical trials. He also serves as the Program Director for Brigham and Women's Hospital's PGY2 Investigational Drugs and Research Pharmacy Residency. Kevin has published and presented on investigational drug and compounding practice and holds the Certified Clinical Research Professional credential through SOCRA. In this conversation, Kevin shares how Investigational Drug Services support clinical trial execution, what sponsors and study teams should understand about pharmacy operations, and how stronger collaboration with IDS can improve the conduct of clinical trials.
Statistics influence almost every major decision in a clinical trial. In this episode, Roseann White, a retired biostatistician with more than 30 years of experience, joins the Clinical Trial Podcast to make biostatistics practical for clinical research professionals. Roseann explains what statistical significance really means, why clinical meaning matters, how to think about superiority and non-inferiority, and why sensitivity and specificity can confuse even experienced teams. We also discuss endpoint selection, statistical analysis plans, financial constraints, FDA disagreements, and the questions non-statisticians should ask earlier in the trial design process. This is a practical conversation for anyone involved in designing, conducting, analyzing, or interpreting clinical trials.
Why do qualified candidates apply to role after role in clinical research and never hear back? In this episode of the Clinical Trial Podcast, we unpack what's really happening behind the scenes in the hiring process. Because getting hired isn't just about your technical skills. It's about how hiring managers assess risk, how recruiters decide who to champion, and who actually gets attention versus who gets ignored. Kunal Sampat is joined by Giovanni Lauricella, Co-Founder and CEO of Lifeblood, an executive search firm specializing in MedTech. With over 15 years of experience placing board members, C-suite leaders, and cross-functional talent globally, Giovanni brings a unique perspective from inside the hiring process. In this episode, you'll learn: Why strong candidates get filtered out before interviews What hiring managers are actually looking for How recruiters decide who to champion for What it really takes to break into and advance in clinical research If you've ever felt stuck in your job search or wondered why the process feels like a black box, this conversation will give you a clearer understanding of how hiring decisions are actually made.
What separates strong clinical research from misleading conclusions? Often, it comes down to study design. In this episode of the Clinical Trial Podcast, Kunal Sampat sits down with Dr. Thomas Newman, Professor of Epidemiology and Biostatistics at UCSF and co-author of Designing Clinical Research, to break down how observational studies actually work. While randomized controlled trials are often considered the gold standard, observational studies are essential in many real-world settings. But they come with challenges including bias, confounding, and misinterpretation that can lead to flawed conclusions if not handled correctly. Dr. Newman shares a practical framework to help you design better studies, interpret results more critically, and build a stronger foundation in clinical research. In this episode, you'll learn: When observational studies are more appropriate than randomized trials A practical framework for designing observational research Key threats to validity: bias, confounding, and chance How to interpret associations vs. causal effects Strategies for dealing with confounders in analysis How to approach statistics with more clarity and confidence About the guest: Dr. Thomas Newman, MD, MPH, is a Professor of Epidemiology and Biostatistics at the University of California, San Francisco. His work focuses on applying epidemiologic methods to important clinical problems in child health, including neonatal jaundice, infections in newborns, and cholesterol screening. He is widely recognized for his contributions to clinical research education and is co-author of Designing Clinical Research and Evidence-Based Diagnosis. Why this episode matters: If you want to grow in clinical research, you need more than surface-level knowledge - you need to understand how studies are designed and where they can go wrong. This episode helps you think like a clinical researcher.
Bringing a high-risk cardiovascular device from concept to patient care requires more than innovation - it requires carefully designed clinical trials, strong operational execution, and close collaboration with regulators and physician investigators. In this episode of the Clinical Trial Podcast, Kunal Sampat speaks with Nicole Haratani about how cardiovascular device clinical trials are actually designed and run. Nicole is Vice President of Clinical Affairs at Supira Medical and has spent more than two decades working in medical device clinical research, particularly in cardiovascular technologies. Nicole shares insights from her experience leading clinical and regulatory programs across feasibility and pivotal trials, and explains the operational realities behind Class III device studies. In this episode, we discuss: How cardiovascular devices move from concept to clinical trials Designing feasibility and pivotal trials for Class III devices How inclusion and exclusion criteria are developed Challenges in patient recruitment for cardiovascular studies Collaborating with key opinion leaders and investigators Working with the FDA during the PMA process Career advice for professionals interested in medical device clinical research If you're interested in cardiovascular device development, clinical trial operations, or building a career in medical device research, this episode provides a practical look at how complex device trials are executed.
Clinical trial budgeting remains one of the biggest bottlenecks in study startups, driving delays, rework, and frustration across sponsors, CROs, and research sites. In this episode of the Clinical Trial Podcast, recorded live at Research Revolution, a clinical research conference hosted by Florence Healthcare, we take a hard look at why clinical trial budget negotiations continue to break down—and what experienced operators are doing differently. This conversation brings together sponsor, site, and consultant perspectives to unpack the real drivers of delay, including slow escalation pathways, unclear or inconsistent budget justifications, misaligned expectations, and communication gaps between stakeholders. Rather than rehashing theory, this episode focuses on practical, experience-driven insights you can actually apply. In this episode, you'll learn: The most common causes of delays during clinical trial budget negotiations How sites can create clear, defensible budget justifications without triggering endless revision cycles What sponsors look for when approving higher-than-expected line items Best practices for internal rate cards, fee schedules, and budgeting templates How improved communication and transparency can reduce negotiation friction and speed study startup This episode features insights from: Kristen McKenna, Senior Manager and Investigator Contracts Lead at Pfizer Heidi Castle, Director of Business Development at Mercy Research Matt Lowery, CEO and Principal Consultant at The Pathways Group If you're involved in clinical trial budgeting, contracting, or study startup - whether at a sponsor, CRO, or research site - this episode offers practical insights to help you navigate negotiations more effectively and avoid common pitfalls. Listen to the episode to hear how sponsor, site, and consultant leaders approach clinical trial budgeting and study startup.
Risk-based monitoring has been discussed in clinical research for more than a decade, yet many organizations still struggle to implement it in a meaningful and effective way. In this episode of the Clinical Trial Podcast, we sit down with Dr. Artem Andrianov, a leading expert in clinical data quality and risk-based quality management, to unpack what risk-based monitoring really means in today's regulatory landscape. Artem has over 25 years of experience in the pharmaceutical industry and is the CEO and cofounder of Cyntegrity a company that specializes in data driven risk management in clinical trials. Together, they explore how the industry has evolved from traditional monitoring approaches to a more holistic model centered on risk-based quality management and quality by design. Dr. Andrianov shares practical insights on common misconceptions, why simply reducing monitoring is not a strategy, and how technology and analytics can be used to proactively manage risk. The conversation also examines the changing role of CRAs, and the growing expectations from regulators and inspectors.
In this episode of the Clinical Trial Podcast, host Kunal Sampat sits down with Dr. Philip Räth, Managing Director of Palleos Healthcare, to discuss leading Clinical Research Organization (CRO) in the European Union (EU). Managing a Clinical Research Organization is far more than project oversight. CRO leaders juggle sponsor expectations, site relationships, internal talent, regulatory demands, and profitability. A strong CRO partner can jumpstart a clinical trial for industry or academic sponsors that have limited infrastructure. A mismatched CRO, on the other hand, can derail timelines, add cost, and create friction you don't need. About Today's Guest: Dr. Philip Räth Dr. Räth brings 15 years of experience in the medical product industry and currently leads Palleos Healthcare, a central European full-service CRO supporting pre-clinical consulting through large-scale clinical trials. Operations in 19 countries 336+ projects delivered Expertise across 23 therapeutic areas In this episode, you'll learn: What makes a CRO truly sponsor-ready Where CRO selection often goes wrong How digital transformation and AI are reshaping CRO operations Insights from Palleos' work across Europe and diverse therapeutic areas The future of full-service clinical trials from a CRO leader's perspective
Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career. You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Clinical Trial Podcast | Conversations with Clinical Research Experts in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Clinical Trial Podcast | Conversations with Clinical Research Experts as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Kunal Sampat | Educator.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Clinical Trial Podcast | Conversations with Clinical Research Experts publishes monthly. Our AI generates a summary within hours of each new episode.
Clinical Trial Podcast | Conversations with Clinical Research Experts covers topics including Business, Careers, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.